Omega 3 Fatty Acid Treatment for Pediatric Musculoskeletal Health
Status:
Withdrawn
Trial end date:
2023-09-01
Target enrollment:
Participant gender:
Summary
This is a randomized clinical trial comparing Omegaven® treatment with standard of care
(soybean-based lipid formulation, Intralipid®) on bone health outcomes in infants with
esophageal atresia (EA) undergoing surgical repair at Boston Children's Hospital.
Phase:
Phase 2
Details
Lead Sponsor:
Boston Children's Hospital Boston Children’s Hospital